Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

17 Feb 2011 07:00

RNS Number : 3714B
Halma PLC
17 February 2011
 



 

 

Halma p.l.c.

 

Interim Management Statement

 

17 February 2011

 

 

Halma, the leading safety, health and sensor technology group today makes an Interim Management Statement prior to its financial year end on 2 April 2011, covering the period from 3 October 2010 to date.

 

Based on current trading and forecasts, the Board expects profit (before amortisation of acquired intangibles) for the full year to be in line with current market expectations (see note 2).

 

Revenue in the first six months of the year was 12% ahead of 2009/10 and this trend has continued into the first four months of the second-half year. We have maintained strong returns and good cash generation.

 

The relative performance of each of our sectors and geographic regions has maintained the pattern of the first half with Infrastructure Sensors achieving solid results, Health and Analysis growing strongly and Industrial Safety continuing to deliver improved profitability. All geographic regions are delivering growth and, as expected, we are seeing the strongest growth in emerging economies, reflecting both the increased opportunity in these markets and our ongoing investment.

 

In November 2010, we announced the purchase of Alicat Scientific Inc. (Arizona, USA) and in December 2010, the purchase of Accudynamics Inc. (Massachusetts, USA). Both businesses are trading in line with our expectations as part of our Fluid Technology businesses within the Health and Analysis sector. These acquisitions demonstrate Halma's ability to identify and buy high quality businesses in our selected markets. We are continuing to search for such opportunities in all three sectors.

 

There have been no material events or transactions impacting the Group's financial position which remains robust and provides us with adequate resources for further acquisitions.

 

The results for the financial year ending 2 April 2011 are expected to be released on 21 June 2011.

 

 

For further information, please contact:

 

Halma p.l.c. Tel: +44 (0)1494 721111

Andrew Williams, Group Chief Executive

Kevin Thompson, Group Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

The Board believes current market forecasts to be in the range of £100m to £106.4m with a consensus of £102.7m (2009/10 profit before amortisation of acquired intangibles: £86.2m).

 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMGMZNVKGMZM
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.